Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Income towards Parent Company: 2020-2021

Historic Income towards Parent Company for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2021 value amounting to -$42.9 million.

  • Milestone Pharmaceuticals' Income towards Parent Company fell 2.33% to -$14.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$58.2 million, marking a year-over-year change of. This contributed to the annual value of -$42.9 million for FY2021, which is 14.24% up from last year.
  • As of FY2021, Milestone Pharmaceuticals' Income towards Parent Company stood at -$42.9 million, which was up 14.24% from -$50.0 million recorded in FY2020.
  • In the past 5 years, Milestone Pharmaceuticals' Income towards Parent Company ranged from a high of -$42.9 million in FY2021 and a low of -$50.0 million during FY2020.
  • Its 2-year average for Income towards Parent Company is -$46.4 million, with a median of -$46.4 million in 2020.
  • Data for Milestone Pharmaceuticals' Income towards Parent Company shows a peak YoY climbed of 14.24% (in 2021) over the last 5 years.
  • Over the past 2 years, Milestone Pharmaceuticals' Income towards Parent Company (Yearly) stood at -$50.0 million in 2020, then rose by 14.24% to -$42.9 million in 2021.